The Centre National de Génotypage (CNG) was established in 1997 by the Ministry of Research and Innovation and in 2007 became part of the Commissariat à l'Energie Atomique (CEA).
The mission of the CNG is to develop and to apply genomic, bioinformatics and statistical methods, principally in order to identify, characterise and translate into clinics the genetic basis of human disease.
